Paying prices we can ill afford

Paying prices we can ill afford

Medicines for Ireland claims policies on biosimilar products prevent taxpayers from gaining €25 million in savings on vital medicines

In a recent examination of hospital costs, the Department of Public Expenditure highlighted a €115 million increase in spending on medicines between 2014 and 2017.

Public hospitals spent €451 million on medicines in 2017 – up from €336 million in 2014.

Hospital expenditure only represents a fraction of the HSE’s total bill on medicines, as the bulk of expenditure emanates from medicines that are dispensed from pharmacies under various state drug schemes.

Subscribe from just 1€

Exclusive offers

Choose the subscription that is right for you

Monthly Subscription

€1

For the first month

€19.99 Monthly Thereafter

Subscribe today

Cancel anytime

Annual Subscription

€200€149

For the first year

€199.99 annually thereafter

Subscribe today

Cancel anytime

Quarterly Subscription

€55€42

For the first 90 days

€55.00 quarterly Thereafter

Subscribe today

Cancel anytime

These offers are not available for current subscribers. Offers and pricing are subject to change without notice.

Terms & Conditions Apply

Please Subscribe or Log in to continue

Subscribe Login

Related Articles

More from The Business Post